Lyell Immunopharma (LYEL) FCF Margin Growth (1y) (2021 - 2026)
Lyell Immunopharma (LYEL) FCF Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Lyell Immunopharma | 326.39 Mn | 326.39 Mn | - | -41.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41.91 Mn |
| Mar 31, 2026 | -114.58 Mn |
| Dec 31, 2025 | -12.36 Mn |
| Sep 30, 2025 | -8.36 Mn |
| Jun 30, 2025 | -14.08 Mn |
| Mar 31, 2025 | 61.73 Mn |
| Dec 31, 2024 | -9.37 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | -14.47 Mn |
| Mar 31, 2024 | -132.81 Mn |
| Dec 31, 2023 | -33.32 Mn |
| Sep 30, 2023 | 163.39 Mn |
| Jun 30, 2023 | -14.84 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | 326,038.00 |
| Sep 30, 2022 | -177.39 Mn |
| Jun 30, 2022 | 89,307.00 |
| Mar 31, 2022 | -674,450.00 |
| Dec 31, 2021 | -72,025.00 |
| Sep 30, 2021 | 225,914.00 |